MétaCan
Menu
← Back to cohort
Record W3182434253 · doi:10.5203/jcanpa.v3i7.900

Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib. : Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib.

2021· article· en· W3182434253 on OpenAlexaff
Allen Szabon

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsAlberta Health Services
Fundersnot available
KeywordsMedicineWarfarinRivaroxabanDabigatranEdoxabanAtrial fibrillationStroke (engine)ApixabanAnticoagulantIntensive care medicineInternal medicine

Abstract

fetched live from OpenAlex

Purpose: Preventing thromboembolic (TE) events "such as stroke" is an essential part of managing patients with nonvalvular atrial fibrillation (Afib).Over the last 50 years, oral anticoagulant treatment with the Vitamin K Antagonist (VKA) Warfarin has played a crucial role in the secondary prevention of Stroke for Afib patients.Research suggests the new direct oral anticoagulant (DOACs) appears to have dominance over Warfarin for Afib treatment in the context of stroke prevention, and for the most part, superior to Warfarin in the secondary stroke prevention in patients with non-valvular Afib.Nevertheless, what does the evidence tell us about risk versus benefits?Method: This literature review conducts a systematic review of the advantages and disadvantages of DOACs, namely dabigatran, rivaroxaban, apixaban and edoxaban, compared with Warfarin in patients with (non-valvular) Afib.The review's search terms included Oral Anticoagulants, Anticoagulants, Direct Oral Anticoagulants, New Oral Anticoagulants, Warfarin, and secondary prevention non-valvular Afib, Afib, Stroke prevention and Stroke.The search resulted in sixty articles selected.Following a full-text review, twenty articles were excluded.The excluded articles included six non-English languages, eight previously identified, and six others did not fulfill the inclusion criteria of "Warfarin versus DOACs prevention of Stroke in Patients with Afib."The remaining articles were reviewed to analyze the advantages and disadvantages of DOACs versus Warfarin in patients in preventing TE stroke in people with non-valvular atrial fibrillation.Conclusion: The findings of this systematic literature review suggest that in the secondary prevention of stroke in patients with non-valvular Afib, DOACs, demonstrate a significant advantage and enhanced safety profile over Warfarin in reducing the risk of thromboembolic stroke compared with Warfarin.As such, DOACs should be considered first-line therapy in the secondary prevention of stroke in patients with non-valvular Afib.Compared with Warfarin, the advantages of DOACs indicated that DOACs are associated with lower life-threatening and intracranial bleeding rates.DOACs rapid onset with peak effect within a few hours, predictable dose responses, reduced or elimination of routine monitoring, and few, if any, important food or drug interactions, and simplify management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.004
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.003
Bibliometrics0.0040.003
Science and technology studies0.0000.000
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.312
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→